CovidResearchTrials by Shray Alag

CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)

Relaxation BreathingWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (1)

Name (Synonyms) Correlation
drug1216 Inspiratory Muscle Training Wiki 1.00

Correlated MeSH Terms (1)

Name (Synonyms) Correlation
D053120 Respiratory Aspiration NIH 0.38

Correlated HPO Terms (0)

Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials

1 Telehealth-Delivered Preoperative Inspiratory Muscle Training: An Innovative Solution to Conserve Scarce ICU Resources

In light of the corona virus pandemic (COVID-19), there is critical need to conserve scarce mechanical ventilation (MV) resources. This study evaluates an intervention in non-infected cardiac patients as a means to assist with minimizing MV and ICU length of stay (LOS). Pre-op inspiratory muscle training (IMT) has been shown to decrease pulmonary complications, MV dependence, and ICU LOS following thoracic surgery. The investigators aim to determine the mechanism of remodeling in diaphragms of adults who undergo pre-op IMT.

NCT04423614 Mechanical Ventilation Complication Other: Inspiratory Muscle Training Other: Relaxation Breathing
MeSH:Respiratory Aspiration

Primary Outcomes

Description: Maximal inspiratory pressure will be quantified in cm of water pressure.

Measure: Maximal inspiratory pressure

Time: Post breathing exercise sessions (up to 4 weeks)

Description: Histology will be used to determine fiber type and cross-sectional area using primary antibodies for laminin and type-specific myosin heavy chain, followed by a triple immunofluorescence-conjugated secondary antibody labeling technique.

Measure: Muscle fiber cross-sectional area and fiber type proportion.

Time: Intra-operatively

Secondary Outcomes

Description: Spirometry will be used to measure peak expiratory flow during a voluntary cough maneuver. It will be quantified in liters per second.

Measure: Peak expiratory flow

Time: Post breathing exercise sessions (up to 4 weeks)

Description: Time to extubation will be measured as hours of post-operative mechanical ventilation.

Measure: Time to extubation

Time: Up to discharge from ICU

Description: Length of ICU stay will be measured as hours spent in ICU after surgery.

Measure: Length of ICU stay

Time: Up to 1 month

Description: Length of hospital stay will be measured as hours spent in hospital after surgery.

Measure: Length of hospital stay

Time: Up to 1 month

Description: Histology will be used to assess neuromuscular junction number and morphology using immunofluorescent-labeled antibodies for synaptophysin and alpha bungarotoxin. Neuromuscular junction image stacks will be visualized with confocal microscopy and morphology classified according to endplate area and area fractions of fragmented junctions, acetylcholine receptor-occupied endplate area, synaptophysin-occupied endplates, and abandoned endplates.

Measure: Neuromuscular junction morphology

Time: Intra-operatively

Description: RNA isolation will be performed using Tri Reagent and chloroform based manual method. RNA will be quantified and RNA-Seq will be used to assess gene expression.

Measure: Muscle differential gene expression

Time: Intra-operatively

Description: Physical function will be assessed with the Patient Reported Outcomes Measurement Information System Physical Function questionnaire. Each answer corresponds to a number between 1 and 5.

Measure: Physical Function

Time: Post breathing exercise sessions (up to 4 weeks)

Description: Dyspnoea will be assessed with the Dyspnoea 12 Questionnaire. Responses range from None to Severe.

Measure: Dyspnoea

Time: Post breathing exercise sessions (up to 4 weeks)

No related HPO nodes (Using clinical trials)